Back to Search Start Over

Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age.

Authors :
de Morais TL
Giribela C
Nisenbaum MG
Guerra G
Mello N
Baracat E
Consolim-Colombo FM
Source :
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2014 Nov; Vol. 182, pp. 113-7. Date of Electronic Publication: 2014 Sep 16.
Publication Year :
2014

Abstract

Unlabelled: The use of combined oral contraceptives is widespread among hypertensive women despite being associated with increased cardiovascular risk. Contraceptives containing drospirenone, which has antimineralocorticoid properties, may have a positive or neutral effect on neurohumoral activation and metabolic homeostasis of hypertensive women at reproductive age.<br />Objectives: To evaluate the effect of combined oral contraceptive containing drospirenone+ethinylestradiol on the systemic blood pressure, metabolic variables and neurohumoral axis in hypertensive women in reproductive age.<br />Design: Prospective controlled trial with 56 hypertensive women allocated in two groups: 30 volunteers under oral combined contraceptive use and 26 volunteers using non-hormonal contraceptive methods. Subjects were tested before the introduction of the contraceptive method and 6 months after its use. For data acquisition, we used continuous non-invasive beat-to-beat blood pressure curve recordings and, for the biochemical and hormonal analyses two blood samples were obtained. Student's t test was used to determine differences between groups and moments and p<0.05 was considered statistically significant.<br />Results: Comparing antropometric and blood pressure measurements, cardiac sympatho-vagal modulation, baroreceptor sensitivity, metabolic and neurohumoral axis variables between baseline and after 6 months, no significant difference was detected in each group or between groups. Except serum triglyceride levels which increased in the group of women using EE+DRSP after 6 months of use.<br />Conclusion: A contraceptive containing 20 mcg of ethinyl estradiol and 3 mg of drospirenone causes no significant changes in clinical and autonomic parameters, metabolic variables and neurohumoral axis of hypertensive women.<br /> (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1872-7654
Volume :
182
Database :
MEDLINE
Journal :
European journal of obstetrics, gynecology, and reproductive biology
Publication Type :
Academic Journal
Accession number :
25268778
Full Text :
https://doi.org/10.1016/j.ejogrb.2014.09.006